−£7.25m
vs Mar 2024Liquidation08845124Private limited companyLondon
REBIO TECHNOLOGIES LIMITED
Significant control: Rebio Technologies Limited (75–100%)
In liquidationThe company is being wound up. A liquidator deals with its affairs, assets and creditors' claims. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Rebio Technologies Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Rebio Technologies Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
REBIO TECHNOLOGIES LIMITED is a liquidation private limited company (company number 08845124) incorporated on 14 January 2014, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£7.25m and cash of £23k, with 4 employees on average. Net assets fell 7% on the prior period (−£6.77m).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Rebio Technologies Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 14 January 201412 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 28 January 2027in 96 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£23k
−87%vs Mar 2024Not reported
4
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£7.25m | £23k | £82k | — | — | — | 4 |
| 31 March 2024 | −£6.77m | £183k | £410k | — | — | — | 4 |
Cash per employee£5,828Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-7,248,004 at 31 March 2025
- Incorporated five or more years agoIncorporated 14 January 2014
- Register status is not ActiveLiquidation
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 96 days
- Next accounts duein 68 days
- Accounts period endNet liabilities £7.25m · small accounts
- Accounts period endNet liabilities £6.77m · small accounts
- Incorporated
08
Similar companies in London
- CHAIN BIOTECHNOLOGY LIMITEDLondon · inc. Jan 2014
- PHOENIX DX LTDLondon · inc. Jan 2014
- SIME DIAGNOSTICS LIMITEDLondon · inc. Feb 2014
- PHELIX RESEARCH AND DEVELOPMENTLondon · inc. Dec 2013
- BUGS BIOSCIENCE LIMITEDLondon · inc. Feb 2014
- MEDCITY LTDLondon · inc. Nov 2013
All companies incorporated on 14 January 2014 · in Jan 2014.
09
Reminders for REBIO TECHNOLOGIES LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.